Search Results

Filter
  • 1-10 of  232 results for ""MYELODYSPLASTIC syndromes""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Haematological features of telomere biology disorders diagnosed in adulthood: A French nationwide study of 127 patients.

  • Authors : Maillet F; Hematology and Transplant Unit, French Reference Center for Aplastic Anemia, Saint-Louis Hospital, AP-HP, Université Paris Cité, Paris, France.; Galimard JE

Subjects: Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/genetics ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/mortality; Humans

  • Source: British journal of haematology [Br J Haematol] 2024 Nov; Vol. 205 (5), pp. 1835-1847. Date of Electronic Publication: 2024 Sep 15.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Flow cytometric analysis of peripheral blood neutrophil myeloperoxidase expression in myelodysplastic neoplasms (MPO-MDS-Valid): protocol for a multicentre diagnostic accuracy study.

  • Authors : Planta C; Univ. Grenoble Alpes, TIMC, UMR 5525, CNRS, France, Grenoble, France.; Laboratoire d'Immunologie, Grenoble Alpes University Hospital, Grenoble, France.

Subjects: Flow Cytometry* ; Peroxidase*/Peroxidase*/Peroxidase*/blood ; Peroxidase*/Peroxidase*/Peroxidase*/metabolism

  • Source: BMJ open [BMJ Open] 2024 Jun 17; Vol. 14 (6), pp. e081200. Date of Electronic Publication: 2024 Jun 17.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Eltrombopag for myelodysplastic syndromes or chronic myelomonocytic leukaemia with no excess blasts and thrombocytopenia: a French multicentre retrospective real-life study.

Subjects: Benzoates/Benzoates/Benzoates/*therapeutic use ; Hydrazines/Hydrazines/Hydrazines/*therapeutic use ; Leukemia, Myelomonocytic, Chronic/Leukemia, Myelomonocytic, Chronic/Leukemia, Myelomonocytic, Chronic/*drug therapy

  • Source: British journal of haematology [Br J Haematol] 2021 Jul; Vol. 194 (2), pp. 336-343. Date of Electronic Publication: 2021 Jun 20.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Transfusional iron overload in patients with myelodysplastic syndromes: A 10-year retrospective survey from a French general hospital.

  • Authors : Bauduer F; Service d'hématologie, centre hospitalier de la Côte Basque, Bayonne, France; Unité d'hémovigilance, centre hospitalier de la Côte Basque, Bayonne, France

Subjects: Erythrocyte Transfusion/Erythrocyte Transfusion/Erythrocyte Transfusion/*adverse effects ; Iron Overload/Iron Overload/Iron Overload/*etiology ; Myelodysplastic Syndromes/Myelodysplastic Syndromes/Myelodysplastic Syndromes/*therapy

  • Source: Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine [Transfus Clin Biol] 2020 Aug; Vol. 27 (3), pp. 128-132. Date of Electronic Publication: Publisher: Elsevier Science Country of Publication: France NLM ID: 9423846 Publication Model: Print-Electronic Cited Medium:

Record details

×
Report

Azacitidine in patients older than 80 years with acute myeloid leukaemia or myelodysplastic syndromes: a report on 115 patients.

Subjects: Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*therapeutic use ; Azacitidine/Azacitidine/Azacitidine/*therapeutic use ; Leukemia, Myeloid, Acute/Leukemia, Myeloid, Acute/Leukemia, Myeloid, Acute/*drug therapy

  • Source: British journal of haematology [Br J Haematol] 2020 Aug; Vol. 190 (3), pp. 461-464. Date of Electronic Publication: 2020 May 11.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Adverse transfusion reactions in patients with aplastic anaemia or myelodysplastic syndromes.

Subjects: Anemia, Aplastic/Anemia, Aplastic/Anemia, Aplastic/*therapy ; Blood Component Transfusion/Blood Component Transfusion/Blood Component Transfusion/*adverse effects ; Erythrocyte Transfusion/Erythrocyte Transfusion/Erythrocyte Transfusion/*adverse effects

  • Source: Vox sanguinis [Vox Sang] 2019 May; Vol. 114 (4), pp. 349-354. Date of Electronic Publication: 2019 Feb 28.Publisher: Blackwell Science Country of Publication: England NLM ID: 0413606 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Association between health literacy, communication and psychological distress among myelodysplastic syndromes patients.

  • Authors : Ousseine YM; Aix-Marseille Univ, INSERM, IRD, SESSTIM, 'Cancer, Biomedicine & Society' Group, Marseille, France.; Butow PN

Subjects: Health Literacy* ; Myelodysplastic Syndromes* ; Physician-Patient Relations*

  • Source: Leukemia research [Leuk Res] 2018 Oct; Vol. 73, pp. 44-50. Date of Electronic Publication: 2018 Sep 05.Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications.

  • Authors : Pleyer L; 3rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg, Austria. .; Center for Clinical Cancer and Immunology Trials at Salzburg Cancer Research Institute, Salzburg, Austria. .

Subjects: Azacitidine/Azacitidine/Azacitidine/*therapeutic use ; Leukemia, Myeloid/Leukemia, Myeloid/Leukemia, Myeloid/*drug therapy ; Myelodysplastic Syndromes/Myelodysplastic Syndromes/Myelodysplastic Syndromes/*drug therapy

  • Source: Journal of hematology & oncology [J Hematol Oncol] 2016 Apr 16; Vol. 9, pp. 39. Date of Electronic Publication: 2016 Apr 16.Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722

Record details

×
Academic Journal

Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study.

  • Authors : Mekinian A; AP-HP, Hôpital Saint Antoine, service de medicine interne and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Paris.; Grignano E

Subjects: Autoimmunity/Autoimmunity/Autoimmunity/*immunology ; Azacitidine/Azacitidine/Azacitidine/*therapeutic use ; Glucocorticoids/Glucocorticoids/Glucocorticoids/*therapeutic use

  • Source: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2016 Feb; Vol. 55 (2), pp. 291-300. Date of Electronic Publication: 2015 Sep 08.Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Contribution of Revised International Prognostic Scoring System Cytogenetics to Predict Outcome After Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: A Study From the French Society of Bone Marrow Transplantation and Cellular Therapy.

  • Authors : Gauthier J; 1 CHRU Lille, Pôle Spécialités Médicales et Gérontologie, Service des Maladies du Sang, Secteur Allogreffe de Cellules Souches Hématopoïétiques, F59037, Lille, France. 2 Université de Lille, UFR Médecine F59000, Lille, France. 3 Hematology Department, Caen University Hospital, Amiens, France. 4 Department of Biostatistics, Lille University Hospital, Lille, France. 5 Hematology Department and Hematopoietic Stem Cell Transplantation Unit, Saint-Louis Hospital, Paris, France. 6 Hematology Department, Lyon-Sud Hospital, Lyon, France. 7 Hematology Department, Nantes, France. 8 Hematology Department CH-Liège, Liège, Belgium. 9 Hematology Department, Pitié-Salpêtrière Hospital, Paris, France. 10 Hematology Department, Strasbourg University Hospital, Strasbourg, France. 11 Hematopoietic Stem Cell Transplantation Unit, Paoli Calmettes Institute, Marseille, France. 12 Hematology Department, Loire Oncology Institute (ICL), Saint Priest en Jarez, France. 13 Hematology Department, Nantes University Hospital, Nantes, France. 14 Hematology Department, Saint-Antoine Hospital, Paris, France. 15 Hematology Department, Toulouse University Hospital, Toulouse, France. 16 Hematology Department, Grenoble University Hospital, Grenoble, France. 17 Hematology Department, Bordeaux University Hospital, Bordeaux, France.; Damaj G

Subjects: Cytogenetic Analysis* ; Decision Support Techniques* ; Stem Cell Transplantation*/Stem Cell Transplantation*/Stem Cell Transplantation*/adverse effects

  • Source: Transplantation [Transplantation] 2015 Aug; Vol. 99 (8), pp. 1672-80.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0132144 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  232 results for ""MYELODYSPLASTIC syndromes""